BORTEZOMIB IN COMBINATION WITH HIGH DOSE MELPHALAN AS CONDITIONING REGIMEN IS SAFE AND IMPROVES THE RESPONSE RATES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Authors
Publication date
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della Ricerca - Università degli Studi di Parma

    redirect
    oaioai:air.unipr.it:11381/2810906
    Last time updated on 09/07/2019